Actos Whistleblower Lawsuit Alleges Takeda Pharmaceuticals Attempted to Influence Reports of Actos Side Effects.

(PRWEB) On 3/19/12, the Consumer Justice Foundation alerted the public of allegations made in an Actos whistleblower lawsuit that accused Takeda Pharmaceuticals of influencing reports of risks of potential Actos side effects.  Actos Whistleblower PRWeb Release 3.19.12

The FDA approved Actos for use in the United States in 1999 to treat symptoms relating to Type II Diabetes. Actos has been banned from use in Germany and France because of the potential risk of long-term use and bladder cancer. On June 15, 2011, the FDA published a public warning alerting long-term American users of Actos of the same risk.  Actos FDA-6.15.11-Safety-Announcement

If you or a family member took Actos, ACTOplus met, actoplus met xr or duetact to treat diabetes for more than one year and have been diagnosed with bladder cancer, please contact us.  John Evans (jcevans@ssem.com), one of our experienced pharmaceutical attorneys, would be pleased to assist you in seeking legal remedies. 

If you or a family member took Actos, ACTOplus met, actoplus met xr or duetact to treat diabetes and suffered a heart attack or stroke, we would be interested in speaking with you.  Please email Mr. Evans at jcevans@ssem.com or give him a call at 1-800-642-5297.

You may also complete the short form below or call us at 1-800-642-5297 for a free, confidential consultation at a time convenient for you.

Your Name (required)

Your Email(required)

Phone Number (required)

Subject

Your Message

captcha

Enter the text above to validate your message